CTOs on the Move

PellePharm

www.pellepharm.com

 
We Develop first in class therapies for basal cell carcinomas, including those in gorlin syndrome.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.pellepharm.com
  • 275 Middlefield Road Suite 100
    Menlo Park, CA USA 94025
  • Phone: 510.502.6144

Executives

Name Title Contact Details

Funding

PellePharm raised $20M on 08/01/2017
PellePharm raised $70M on 11/20/2018

Similar Companies

Phenomenex

Phenomenex is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Texcell NA

Texcell NA is a Frederick, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Viracta

Viracta is focused on advancing a proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr Virus, and will pursue opportunities to address other serious virus-associated disease.

Imvax

The approach is an autologous, cell-based treatment that activates the full array of patient-specific antigens, resulting in both an innate and adaptive immune response. The company`s lead program is in glioblastoma multiforme (GBM), an extremely aggressive form of brain cancer with a significant unmet need. In parallel, the company is also progressing the platform in a select number of additional solid tumors where the unmet need remains great and where initial immunotherapy approaches have often failed to provide a significant benefit.

Enthalpy Analytical

Enthalpy Analytical, Inc. is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.